Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
暂无分享，去创建一个
M. Piccart | G. Hortobagyi | J. Baselga | H. Rugo | M. Gnant | H. Burris | S. Noguchi | K. Pritchard | T. Taran | T. Csoszi | V. Srimuninnimit | H. Burris | P. Puttawibul | M. El-Hashimy | E. Chouinard | Alejandra T. Perez | J. Eakle | M. Geberth | H. Bauly | W. Feng | A. Pérez | T. Csőszi